vs

Side-by-side financial comparison of Quest Diagnostics (DGX) and Raymond James Financial (RJF). Click either name above to swap in a different company.

Raymond James Financial is the larger business by last-quarter revenue ($3.9B vs $2.9B, roughly 1.3× Quest Diagnostics). Raymond James Financial runs the higher net margin — 14.1% vs 9.7%, a 4.4% gap on every dollar of revenue. On growth, Raymond James Financial posted the faster year-over-year revenue change (13.0% vs 9.2%). Over the past eight quarters, Quest Diagnostics's revenue compounded faster (9.9% CAGR vs 1.3%).

Quest Diagnostics Incorporated is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil. Quest also maintains collaborative agreements with various hospitals and clinics across the globe.

Raymond James Financial, Inc. is an American multinational independent investment bank and financial services company providing financial services to individuals, corporations, and municipalities through its subsidiary companies that engage primarily in investment and financial planning, in addition to investment banking and asset management. The company is headquartered in St. Petersburg, Florida.

DGX vs RJF — Head-to-Head

Bigger by revenue
RJF
RJF
1.3× larger
RJF
$3.9B
$2.9B
DGX
Growing faster (revenue YoY)
RJF
RJF
+3.8% gap
RJF
13.0%
9.2%
DGX
Higher net margin
RJF
RJF
4.4% more per $
RJF
14.1%
9.7%
DGX
Faster 2-yr revenue CAGR
DGX
DGX
Annualised
DGX
9.9%
1.3%
RJF

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
DGX
DGX
RJF
RJF
Revenue
$2.9B
$3.9B
Net Profit
$281.0M
$544.0M
Gross Margin
Operating Margin
15.4%
Net Margin
9.7%
14.1%
Revenue YoY
9.2%
13.0%
Net Profit YoY
12.0%
10.0%
EPS (diluted)
$2.24
$2.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DGX
DGX
RJF
RJF
Q1 26
$2.9B
$3.9B
Q4 25
$2.8B
$4.2B
Q3 25
$2.8B
$4.2B
Q2 25
$2.8B
$3.8B
Q1 25
$2.7B
$3.8B
Q4 24
$2.6B
$4.0B
Q3 24
$2.5B
$4.0B
Q2 24
$2.4B
$3.8B
Net Profit
DGX
DGX
RJF
RJF
Q1 26
$281.0M
$544.0M
Q4 25
$245.0M
$563.0M
Q3 25
$245.0M
$604.0M
Q2 25
$282.0M
$436.0M
Q1 25
$220.0M
$495.0M
Q4 24
$222.0M
$600.0M
Q3 24
$226.0M
$602.0M
Q2 24
$229.0M
$492.0M
Gross Margin
DGX
DGX
RJF
RJF
Q1 26
Q4 25
32.4%
Q3 25
33.7%
Q2 25
34.2%
Q1 25
32.5%
Q4 24
32.7%
Q3 24
32.6%
Q2 24
33.5%
Operating Margin
DGX
DGX
RJF
RJF
Q1 26
15.4%
Q4 25
13.8%
Q3 25
13.7%
Q2 25
15.9%
14.7%
Q1 25
13.0%
17.5%
Q4 24
13.8%
18.6%
Q3 24
13.3%
Q2 24
14.8%
17.1%
Net Margin
DGX
DGX
RJF
RJF
Q1 26
9.7%
14.1%
Q4 25
8.7%
13.5%
Q3 25
8.7%
14.4%
Q2 25
10.2%
11.3%
Q1 25
8.3%
12.9%
Q4 24
8.5%
14.9%
Q3 24
9.1%
15.0%
Q2 24
9.6%
13.1%
EPS (diluted)
DGX
DGX
RJF
RJF
Q1 26
$2.24
$2.83
Q4 25
$2.18
$2.79
Q3 25
$2.16
$2.96
Q2 25
$2.47
$2.12
Q1 25
$1.94
$2.36
Q4 24
$1.95
$2.86
Q3 24
$1.99
$2.85
Q2 24
$2.03
$2.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DGX
DGX
RJF
RJF
Cash + ST InvestmentsLiquidity on hand
$393.0M
$5.4B
Total DebtLower is stronger
$5.7B
Stockholders' EquityBook value
$7.7B
$52.0M
Total Assets
$16.7B
$91.9B
Debt / EquityLower = less leverage
0.74×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DGX
DGX
RJF
RJF
Q1 26
$393.0M
$5.4B
Q4 25
$420.0M
$9.9B
Q3 25
$432.0M
$11.4B
Q2 25
$319.0M
$9.2B
Q1 25
$188.0M
$9.7B
Q4 24
$549.0M
$10.0B
Q3 24
$764.0M
$11.0B
Q2 24
$271.0M
$9.1B
Total Debt
DGX
DGX
RJF
RJF
Q1 26
$5.7B
Q4 25
$5.2B
Q3 25
$5.2B
Q2 25
$5.2B
Q1 25
$5.9B
Q4 24
$5.6B
Q3 24
$5.6B
Q2 24
$3.8B
Stockholders' Equity
DGX
DGX
RJF
RJF
Q1 26
$7.7B
$52.0M
Q4 25
$7.2B
$12.6B
Q3 25
$7.3B
$12.5B
Q2 25
$7.2B
$12.3B
Q1 25
$6.9B
$12.2B
Q4 24
$6.8B
$11.9B
Q3 24
$6.8B
$11.7B
Q2 24
$6.6B
$11.2B
Total Assets
DGX
DGX
RJF
RJF
Q1 26
$16.7B
$91.9B
Q4 25
$16.2B
$88.8B
Q3 25
$16.2B
$88.2B
Q2 25
$16.0B
$84.8B
Q1 25
$15.8B
$83.1B
Q4 24
$16.2B
$82.3B
Q3 24
$16.1B
$83.0B
Q2 24
$13.9B
$80.6B
Debt / Equity
DGX
DGX
RJF
RJF
Q1 26
0.74×
Q4 25
0.72×
Q3 25
0.71×
Q2 25
0.72×
Q1 25
0.85×
Q4 24
0.83×
Q3 24
0.83×
Q2 24
0.58×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DGX
DGX
RJF
RJF
Operating Cash FlowLast quarter
$278.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.9%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DGX
DGX
RJF
RJF
Q1 26
$278.0M
Q4 25
$465.0M
$-10.0M
Q3 25
$563.0M
$796.0M
Q2 25
$544.0M
$691.0M
Q1 25
$314.0M
$117.0M
Q4 24
$464.0M
$830.0M
Q3 24
$356.0M
$510.0M
Q2 24
$360.0M
$711.0M
Free Cash Flow
DGX
DGX
RJF
RJF
Q1 26
Q4 25
$307.0M
$-56.0M
Q3 25
$419.0M
$752.0M
Q2 25
$436.0M
$634.0M
Q1 25
$197.0M
$71.0M
Q4 24
$341.0M
$789.0M
Q3 24
$250.0M
$460.0M
Q2 24
$268.0M
$655.0M
FCF Margin
DGX
DGX
RJF
RJF
Q1 26
Q4 25
10.9%
-1.3%
Q3 25
14.9%
17.9%
Q2 25
15.8%
16.5%
Q1 25
7.4%
1.8%
Q4 24
13.0%
19.6%
Q3 24
10.0%
11.5%
Q2 24
11.2%
17.4%
Capex Intensity
DGX
DGX
RJF
RJF
Q1 26
3.9%
Q4 25
5.6%
1.1%
Q3 25
5.1%
1.1%
Q2 25
3.9%
1.5%
Q1 25
4.4%
1.2%
Q4 24
4.7%
1.0%
Q3 24
4.3%
1.2%
Q2 24
3.8%
1.5%
Cash Conversion
DGX
DGX
RJF
RJF
Q1 26
0.99×
Q4 25
1.90×
-0.02×
Q3 25
2.30×
1.32×
Q2 25
1.93×
1.58×
Q1 25
1.43×
0.24×
Q4 24
2.09×
1.38×
Q3 24
1.58×
0.85×
Q2 24
1.57×
1.45×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DGX
DGX

Segment breakdown not available.

RJF
RJF

Private Client Group$2.8B73%
Bank$486.0M13%
Capital Markets$464.0M12%
Other$99.0M3%

Related Comparisons